A study conducted by Spanish scientists has shown that the veterinary antibiotic sarafloxacin is capable of suppressing the replication of the new coronavirus.
A study conducted by the Chemoinformatics and Nutrition Research Group at the Rovira-Virgili University of Tarragona (URV) has shown that sarafloxacin, an antibiotic used in veterinary medicine, can inhibit key enzymes in the replication and transcription process of the new coronavirus.
Studies were conducted as part of the European Covid Moonshot pilot program to confirm the drug’s biological activity, and the results confirm that it is the third of seven drugs identified by the research team as inhibiting the M-pro enzyme.
Experimental results obtained with sarafloxacin also showed that its ability to slow viral replication was even greater than that of the two anti-inflammatory drugs initially tested.
The URV study predicts that among the 6,466 drugs found after computer screening, 7 may have the ability to inhibit M-pro, thereby suppressing viral replication.
The results of the studies of these seven molecules were shared with the international lunar mission to combat COVID-19, which initially confirmed the effectiveness of two of them (carbofen and celecoxib) to test their ability to inhibit the main protease of the virus M-pro in vitro.
As a result, it was established that at a concentration of 50 μmol/L of celecoxib or carbofen, both molecules are capable of reducing the activity of M-pro in vitro (the degree of inhibition by celecoxib was 11.9%, and by carbofen – 4%).
Now they have demonstrated that the veterinary antibiotic sarafloxacin has even higher biological activity, reaching 20% at a concentration of 50 microns.
Although these inhibitors are not very effective, research suggests that these three compounds could serve as a starting point for the development of more effective derivatives.
According to Gerard Pujadas, lead researcher of the research team, this new confirmation shows that the computational approach to URV design is “very effective for discovering M-pro inhibitors in molecular databases.”
Therefore, the researchers stated: “Beyond searching for approved drugs, this computational strategy can be used to search for new drugs for the treatment of COVID-19 in other molecular databases.”
The researchers expect that the remaining four molecules will also be selected in the near future to test their biological activity.
After the death of one parrot, another bird developed symptoms and an outbreak of psittacosis was subsequently discovered in Madrid.
Spanish veterinary experts have expressed concern about restrictions imposed by the Spanish Agency for Medicines and Health Products (AEMPS) on the export of veterinary drugs to Europe.
Elections on November 29: The Spanish Socialist Workers’ Party proposes measures against the abandonment of animals, alternative violence and the rescue of animals in emergency situations.
The information on this page is for veterinary purposes only. Are you a veterinarian?
Post time: Nov-16-2026

